Fri. 19 Apr 2024, 11:41am ET
Benzinga
Biotech, News, Eurozone, Global, Markets, General
Reported Earlier, Travere Therapeutics And CCL Vifor Get European Commission Approval Of Sparsentan For The Treatment Of IgA Nephropathy.
Company Profile